Plunkett Research Online: Medicenna Therapeutics

MEDICENNA THERAPEUTICS (MDNA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recur.....


MEDICENNA THERAPEUTICS

Ticker: MDNA
Exchange: TSX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 416 648-5555
Fax: 416 572-7501
Address: 2 Bloor Street W.
Toronto, ON M4W 3E2 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Fahar MerchantCEO/Chairman of the Board/Director/President
David HymanCFO
See More
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recur.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture